Idenix Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast)

Oct.30.13 | About: Idenix Pharmaceuticals, (IDIX)

Idenix (IDIX): Q3 EPS of -$0.25 misses by $0.04. Revenue of $19K. (PR)

The following audio is from a conference call that will begin on October 30, 2013 at 16:30 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.